Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

3 articles from the last 30 days matching "Quality of Life"

ResearchRSSMay 14

Vyalev eases motor, nonmotor symptoms in advanced Parkinson’s

Vyalev is a new under-the-skin pump that delivers Parkinson's disease medication continuously. In a real-world study, it reduced the amount of time patients experienced symptoms and improved both movement problems and some other symptoms like mood or sleep issues. Patients also reported better quality of life.

WHY IT MATTERSIf you have advanced Parkinson's disease and struggle with medication wearing off between doses, Vyalev offers a continuous delivery option that may reduce symptom fluctuations and improve daily functioning.
💬 Ask your doctorParkinson's disease
ResearchBIORXIVMay 6

Preprint: Variation in Tolvaptan Prescribing for Autosomal Dominant Polycystic Kidney Disease in the United Kingdom and Its Impact on Quality of Life and Costs

A new study looked at how often doctors in the UK prescribe tolvaptan, a medicine that slows kidney disease in patients with ADPKD (a genetic condition where cysts grow in the kidneys). The researchers found that some patients who should get this medicine don't receive it, while others who aren't eligible do get it. This variation in prescribing patterns may affect how well patients do and how much the healthcare system spends.

WHY IT MATTERSIf you have ADPKD in the UK, this research could help explain why access to tolvaptan—the only disease-slowing treatment available—varies depending on which kidney center treats you.
💬 Ask your doctorAutosomal Dominant Polycystic Kidney Disease (ADPKD)
ResearchPUBMEDApr 29

Adenocarcinoma of the small intestine cohort: prospectively collecting real-world data to improve care and quality of life for patients with a rare cancer.

Researchers in the Netherlands are creating a large database to collect information about small intestinal adenocarcinoma, a rare type of cancer that starts in the small intestine. They're gathering medical records, tumor samples, and patient feedback to better understand how this cancer develops and which treatments work best. This study is important because doctors currently don't have enough information to know the best way to treat this disease.

WHY IT MATTERSFor the first time, patients with small intestinal adenocarcinoma will have their disease studied systematically in a large prospective cohort, which could lead to treatment recommendations tailored specifically to this rare cancer instead of borrowed from other gastrointestinal cancers.
ℹ Good to knowsmall intestinal adenocarcinomaadenocarcinoma of the small intestine

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases